<DOC>
	<DOCNO>NCT01716923</DOCNO>
	<brief_summary>The clinical study ass in-vitro characteristic red blood cell ( RBCs ) per European Union ( EU ) criteria leukocyte deplete RBCs additive solution evaluate safety efficacy S-303 treat RBCs patient population require RBC transfusion support acute anemia .</brief_summary>
	<brief_title>Study Assess S303 RBCs Evaluate Safety Efficacy Patients Requiring Transfusion Support Acute Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>1 . Age ≥18 year , either gender . 2 . Must willing use acceptable form contraceptive study ( approve Investigator designee ) 3 . Must readily available telephone 4 . Must provide informed consent study participation sign ethic committee ( EC ) approve informed consent 5 . Must negative cross match S 303 red blood cell ( RBCs ) study entry 6 . Must blood type either A+ O+ 7 . Patients must likelihood receive transfusion determine Investigator OR Transfusion Risk Understanding Screening Tool ( TRUST ) Score ≥3 study entry 8 . Must schedule receive one follow operative procedure : Coronary artery bypass graft , first procedure Valve repair replacement , first procedure A combination first time Coronary Artery Bypass Graft ( CABG ) valve repair replacement After consultation Medical Monitor , provision make enroll patient may meet general criterion whose surgical procedure precisely described category . Such patient classify `` '' explicit condition report study data . 1 . A positive pregnancy test result 2 . Inability patient comply protocol opinion Investigator attend physician 3 . Breastfeeding infant child 4 . Active autoimmune hemolytic anemia , positive Direct Antiglobulin Test ( DAT ) result 5 . Treatment medication know adversely affect red blood cell viability 6 . Emergent salvage surgical status time surgery define follow : Presence ongoing ischemia include angina rest despite maximal medical therapy Acute evolve myocardial infarction within 24 hour surgery Pulmonary edema require intubation Presence shock hemodynamic instability without circulatory support Systolic blood pressure &lt; 80 mm Hg and/or Cardiac Index &lt; 1.8 despite medical intervention ( intravenous inotropes similar pharmacologic agent ) Cardiopulmonary resuscitation 24 hour prior surgery anesthesia induction Requiring intraaortic balloon pump ventricular assist device 7 . Participation one follow type clinical study either concurrently within previous 28 day : investigational blood product , pharmacologic agent image material , include dye , investigational surgical technique , device . Studies nutrition , psychology , socioeconomic issue ground exclusion 8 . Current diagnosis either chronic acute renal failure ( require dialysis ) serum creatinine great equal 1.8 mg/dL within 30 day prior start surgery 9 . Current diagnosis either chronic acute hepatic insufficiency total serum bilirubin great equal 2.0 mg/dL within 30 day prior start surgery 10 . Preexisting RBC antibody may make provision compatible study red blood cell ( RBC ) component difficult 11 . Patients require plasma removal irradiation RBC 12 . Patients prior history severe allergic transfusion reaction 13 . A positive cross match S 303 treat RBC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>